|
Volumn 23, Issue 3, 2002, Pages 278-284
|
Pharmacodynamics and pharmacokinetics of inhaled nitric oxide in dogs with septic acute respiratory distress syndrome
|
Author keywords
Adult respiratory distress syndrome; Nitric oxide; Phosphatidylcholines; Pulmonary surfacants; Respiratory insufficiency; Respiratory therapy
|
Indexed keywords
NITRIC OXIDE;
CD11B ANTIGEN;
CD18 ANTIGEN;
ENDOTOXIN;
MESSENGER RNA;
TUMOR NECROSIS FACTOR ALPHA;
ACUTE RESPIRATORY FAILURE;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ARTICLE;
ARTIFICIAL VENTILATION;
CONTROLLED STUDY;
DRUG EFFECT;
LUNG ALVEOLUS MACROPHAGE;
LUNG COMPLIANCE;
LUNG VASCULAR RESISTANCE;
MEDIATOR RELEASE;
NONHUMAN;
PROTEIN EXPRESSION;
PROVOCATION TEST;
SEPSIS;
ADULT RESPIRATORY DISTRESS SYNDROME;
ANIMAL;
BIOSYNTHESIS;
CHEMICALLY INDUCED DISORDER;
DOG;
ESCHERICHIA COLI;
FEMALE;
GENETICS;
INHALATIONAL DRUG ADMINISTRATION;
LUNG;
MALE;
METABOLISM;
RANDOMIZATION;
SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;
ADMINISTRATION, INHALATION;
ANIMALS;
ANTIGENS, CD11B;
ANTIGENS, CD18;
DOGS;
ENDOTOXINS;
ESCHERICHIA COLI;
FEMALE;
LUNG;
MALE;
NITRIC OXIDE;
RANDOM ALLOCATION;
RESPIRATORY DISTRESS SYNDROME, ADULT;
RNA, MESSENGER;
SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;
TUMOR NECROSIS FACTOR-ALPHA;
|
EID: 0036189026
PISSN: 16714083
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (7)
|
References (17)
|